تنويه من الشركة CHAE
Document60 pages, text from the file; its scanned pages read by AshumOpen DFM’s file
Page 1
28 /08/ 2025
Mr. Hamed Ahmed Ali
CEO
Dubai Financial Market (DFM)
Dubai, United Arab Emirates
Greetings,
Subject: Notification by Lunate Capital Limited on behalf of Chimera UCITS ICAV
Please be informed that Lunate Capital Limited received the enclosed Condensed Interim Report & Unaudited Financial Statements from Chimera UCITS ICAV for the Period 1ˢᵗ of January 2025 to 30ᵗʰ of June 2025.
Sincerely,
Sherif SalemHead of Public Markets
٢٨ / ٠٨ / ٢٠٢٥
السيد / حامد أحمد علي المحترم
الرئيس التنفيذي
سوق دبي المالي (DFM)
دبي، دولة الإمارات العربية المتحدة
تحية طيبة وبعد،
الموضوع: اخطار من شركة لونيت كابيتال ليمتد عن شيميرا يوسيتس ايكاف
نود اعلامكم بأن شركة لونيت كابيتال ليمتد استلمت التقرير المرحلي الموجز والقوائم المالية غير المدققة من شيميرا يوسيتس ايكاف للفترة من ١ يناير ٢٠٢٥ إلى ٣٠ يونيو ٢٠٢٥.
وتفضلوا بقبول وافر الاحترام،
شريف سالممدير إدارة الأسواق المالية
مرفق التقرير السنوي و البيانات من شيميرا يوسيتس ايكاف
Attached: Chimera UCITS ICAV Annual Report and Audited Financial Statements
LUNATE CAPITAL LIMITED12 ᵀᴴ FLOOR, ALMARYAH TOWER,ABU DHABI,UNITED ARAB EMIRATESLUNATE.COM
Lunate Capital Limited is duly licensed and regulated by the ADGM Financial Services Regulatory Authority
Page 2
Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2025 to 30 June 2025ICAV Registration Number: C188915
Page 3
Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2025 to 30 June 2025Contents PageDirectors and Other Information 1Investment Manager’s Report 2Statement of Financial Position 9Statement of Comprehensive Income 12
Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares 15
Statement of Cash Flows 18Notes to the Unaudited Financial Statements 21Schedule of Investments 38Statement of Portfolio Changes 47
Appendix I: Securities Financing Transactions Regulation (“SFTR”) Disclosures 57
Page 4
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 1
Directors and Other InformationDirectors of the ICAVFeargal Dempsey (Irish)1Seif Fikry (Egyptian)2Jason Loveless (British)2Syl O’Byrne (Irish)1Sherif Salem (Egyptian)2Manager
FundRock Management Company S.A.
5, HeienhaffL-1736 SenningerbergGrand Duchy of Luxembourg
Investment Manager and Global Distributor Lunate Capital Limited
Unit 1, Floor 12, Al Maryah Tower, Abu Dhabi Global Market Square, Al Maryah Island
Abu DhabiUnited Arab EmiratesDepositary*Effective from 3 June 2025
The Bank of New York Mellon SA/NV, Dublin Branch The Shipping Office
20-26 Sir John Rogerson's Quay Grand Canal Dock
Dublin 2D02 Y049IrelandUp to 2 June 2025
The Bank of New York Mellon SA/NV, Dublin Branch Riverside II
Sir John Rogerson’s QuayGrand Canal DockDublin 2IrelandRegistered Office of the ICAVArthur Cox BuildingTen Earlsfort TerraceDublin 2D02 T380IrelandSecretaryBradwell LimitedTen Earlsfort TerraceDublin 2D02 T380IrelandIndependent AuditorsDeloitte Ireland LLP
Chartered Accountants and Statutory Auditors 29 Earlsfort Terrace
Dublin 2D02 AY28IrelandIrish Legal AdvisersArthur CoxTen Earlsfort TerraceDublin 2D02 T380Ireland
* Please refer to Note 21 of the financial statements.
1 Independent and Non-executive Director.
2 Non-executive Director.
Administrator, Registrar and Transfer Agent* Effective from 3 June 2025
BNY Mellon Fund Services (Ireland) Designated Activity Company
The Shipping Office
20-26 Sir John Rogerson's Quay Grand Canal Dock
Dublin 2D02 Y049IrelandUp to 2 June 2025
BNY Mellon Fund Services (Ireland) Designated Activity Company
One Dockland CentralGuild Street
International Financial Services Centre Dublin 1
Ireland
Page 5
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025
2Investment Manager’s Report
The Chimera UCITS ICAV Fund ended the first half of 2025 with assets under management of AED 213.8 million. As of the end of June, there are five sub-funds under the Chimera UCITS ICAV Fund, of which one was launched in February 2021, one was launched in August 2023, and the last three were launched in 2024. The sub-funds are the Chimera S&P UAE UCITS ETF (“the First Sub-Fund”), the Chimera S&P Pakistan UCITS ETF (“the Second Sub-Fund”), the Chimera JP Morgan UAE Bond UCITS ETF (“the Third Sub-Fund”), the Chimera S&P Japan UCITS ETF (“the Fourth Sub-Fund”), and Chimera S&P Germany UCITS ETF (“the Fifth Sub-Fund”).
Chimera S&P UAE UCITS ETF (“the First Sub-Fund”)
The Chimera S&P UAE UCITS ETF has two share classes launched on 23 February 2021, an accumulating share class listed on the Dubai Financial Market (DFM) that replicates the S&P UAE BMI Liquid 20/35 Capped Index NTR (Bloomberg Code:
SPUAECAN) and an income share class listed on the Abu Dhabi Securities Exchange (ADX) that replicates the S&P UAE BMI Liquid 20/35 Capped Index (Bloomberg Code: SPUAECAP). The dividends received by the fund’s income share class are intended to be distributed semi-annually when available. As of 30 June 2025, the DFM-listed Share Class A (Bloomberg code:
CHAE) had a NAV of AED 6.480, and the ADX-listed Share Class D (Bloomberg code: UAED) had a NAV of AED 5.587.
For the first half of 2025, the fund's return was 15.1% compared to the S&P UAE BMI Liquid 20/35 Capped Index’s (the “Index”) return of 15.9%. Since inception, the fund’s return has been 76.6% compared to the index’s 85.1%.
In the second quarter of 2025, a dividend of AED 0.1076 was announced for the ADX-listed Share Class D, yielding 1.9% based on the end-of-June NAV. The ex-dividend date was 30 June 2025, and the payment date is set for 21 July 2025.
* The Fund and Index data specified in the graph are calculated since the inception of the Fund
Page 6
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 3
Investment Manager’s Report (continued)
Chimera S&P UAE UCITS ETF (“the First Sub-Fund”) (continued) Tracking Difference & Tracking Error
The Fund's tracking difference in 1H2025 was -84.3 bps, of which 45.6 bps were management fees, resulting in a gross tracking difference of -38.7 bps.
2021 2022 2023 2024 1H2025 ITD
Fund Return*35.1%-4.8%2.0%17.0%15.1%76.6%
Index Return*36.4%-3.9%2.9%18.3%15.9%85.1%
Tracking Diff (bps)-133.1-90.4-97.7-129.3-84.3-851.6
TER (bps)88.671.495.094.345.6419.6
Tracking Diff gross (bps)-44.5-18.9-2.7-35.1-38.7-432.0
Annualized Tracking Error (bps)33.413.413.010.927.419.8
*All returns are in base currency (AED)
As stated under the Investment Policy of the Chimera S&P UAE UCITS ETF Supplement, it is expected, but not guaranteed, that the level of annual Tracking Difference shall not exceed 2% and the level of annualized Tracking Error shall not exceed 1%, in normal market conditions.
Assets Under Management
The Assets Under Management (AUM) of the Chimera S&P UAE UCITS ETF Fund as of 30 June 2025 was AED 159.6 million. The AUM of Share Class D – Distributing (UAED), listed on the Abu Dhabi Securities Exchange (ADX) were AED 156.4 million, while the AUM of Share Class – A – Accumulating (CHAE), listed on the Dubai Financial Market (DFM) were AED 3.2 million as of 30 June 2025.
Both share classes saw no primary activity during the first half of 2025. The ADX-listed share class (UAED) traded AED 624.8 thousand, while the DFM-listed share class (CHAE) traded AED 647.5 thousand in the secondary market during 1H2025.
The S&P UAE BMI Liquid 20/35 Capped Index was rebalanced twice in the first half of 2025. Two additions and two deletions occurred in the first quarter, and two additions and two deletions occurred in the second quarter.
Chimera S&P Pakistan UCITS ETF (“the Second Sub-Fund”)
The Chimera S&P Pakistan UCITS ETF was launched on 17 August 2023. The fund replicates the S&P Pakistan BMI Liquid 35/20 Capped Index (Bloomberg code: SPPKRCAP), which tracks the performance of the 15 biggest and most liquid stocks listed on the Pakistan Stock Exchange. The fund has one share class – Share Class D Income (Bloomberg code: PKSTN) – and dividends received by the fund are intended to be distributed semi-annually when available.
As of 30 June 2025, the fund’s NAV was PKR 692.941 (AED 8.970). For the first half of 2025, the fund's return in PKR was 5.2% versus the S&P Pakistan BMI Liquid 35/20 Capped Index’s (the “Index”) return of 6.5%. Since inception, the fund’s return is 134.1% versus the index’s 130.3% return.
Page 7
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 4
Investment Manager’s Report (continued)Chimera S&P Pakistan UCITS ETF (“the Second Sub-Fund”) (continued)
* The Fund and Index data specified in the graph are calculated since the inception of the Fund
Tracking Difference
The tracking difference for the Fund in 1H2025 was -133.0 bps, of which 48.8 bps is attributed to management fees, resulting in a gross tracking difference of -84.2 bps. One of the primary causes of this variance is that the fund paid a realized CGT of approximately 39.4 bps and 60.0bps in February 2025 and April 2025. Since the index is a price return index, it does not account for dividends. In 1H2025, the annualized tracking error was 111.1 bps.
2023 2024 1H2025 ITD
Fund Return*23.8%79.7%5.2%134.1%
Index Return*19.4%81.1%6.5%130.3%
Tracking Diff (bps)442.0-135.9-133.0378.0
Total Expense Ratio (bps)36.697.948.8184.6
Tracking Diff gross (bps)478.6-38.084.2562.6
Annualized Tracking Error (bps)29.076.0111.181.1
*All returns are in base currency (PKR)
As stated under the Investment Policy of the Chimera S&P Pakistan UCITS ETF Supplement, it is expected, but not guaranteed, that the level of annual Tracking Difference shall not exceed 2% and the level of annualized Tracking Error shall not exceed 1%, in normal market conditions.
Assets Under Management
As of 30 June 2025, the Chimera S&P Pakistan UCITS ETF had Assets Under Management (AUM) of PKR 629.9 million (AED 9.0 million). During the first half of 2025, the ETF witnessed no primary activity. In the secondary market, the ETF traded for AED 417.9 thousand.
The S&P Pakistan BMI Liquid 35/20 Capped Index was rebalanced twice in the first half of 2025. Two additions and two deletions were made in the first quarter, and one addition and one deletion were made in the second quarter.
Page 8
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 5
Investment Manager’s Report (continued)Chimera JP Morgan UAE Bond UCITS ETF (“the Third Sub-Fund”)
The Chimera JP Morgan UAE Bond UCITS ETF was launched on 25 March 2024. The fund aims to replicate the performance of the J.P Morgan MECI UAE Investment Custom Index, which tracks the performance of liquid, USD-denominated investment-grade instruments from the United Arab Emirates (UAE). The fund has one share class – Share Class D Distributing (Bloomberg code: BONDAE) – and interest received by the fund are intended to be distributed semi-annually when available.
The ETF ended the first half of 2025 with an NAV of USD 1.021 (AED 3.751). During the first half of 2025, the fund’s return in USD (the base currency) was 3.7% versus the J.P Morgan MECI UAE Investment Custom Index’s (the “Index”) return of 4.1%.
Since inception, the fund’s return was 5.7% versus Index’s 7.4% return.
* The Fund and Index data specified in the graph are calculated since inception of the Fund
Tracking Difference & Tracking Error
The tracking difference for the Fund in 1H2025 was 41.1 bps, of which 24.6 bps were management fees, resulting in a gross tracking difference of -16.6 bps. The primary cause of this tracking difference is the trading cost. During the first half of 2025, the annualized tracking error was 54.8 bps.
2024 1H2025 ITD
Fund Return*1.9%3.7%5.7%
Index Return*3.1%4.1%7.4%
Tracking Diff (bps)-122.9-41.1-169.7
Total Expense Ratio (bps)38.624.663.0
Tracking Diff gross (bps)-84.3-16.6106.7
Annualized Tracking Error (bps)62.254.859.4
* All returns are in base currency (USD)
Page 9
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 6
Investment Manager’s Report (continued)
Chimera JP Morgan UAE Bond UCITS ETF ("the Third Sub-Fund") (continued)
Tracking Difference & Tracking Error (continued)
As stated under the Investment Policy of the Chimera JP Morgan UAE Bond UCITS ETF Supplement, it is expected, but not guaranteed, that the level of annual Tracking Difference gross of fees shall not exceed 2% and the level of annualized Tracking Error shall not exceed 1%, in normal market conditions.
Assets Under Management
During the first half of 2025 the Chimera JP Morgan UAE Bond UCITS ETF had Assets Under Management (AUM) of USD 5.1 million (AED 18.7 million). During the first half of 2025, the ETF did not witness any primary activity. In the secondary market, the total traded value of the ETF traded for AED was 2.4 million.
There were five monthly rebalancing of the J.P Morgan MECI UAE Investment Custom Index from January to July, resulting in a total of 20 additions and 10 deletions. Given that the ETF follows a sampling strategy, the ETF had 10 additions and 10 deletions during the same period.
Chimera S&P Japan UCITS ETF (“the Fourth Sub-Fund”)
The Chimera S&P Japan UCITS ETF was launched on 28 May 2024. The fund replicates the S&P Japan BMI Liquid 35/20 Capped Index (Bloomberg code: SPJPLCAP), which tracks the performance of the 30 biggest and most liquid stocks listed on the Tokyo Stock Exchange. The fund has one share class – Share Class D Income (Bloomberg code: JPANI) – and dividends received by the fund are intended to be distributed semi-annually when available.
As of 30 June 2025, the fund’s NAV was JPY 162.954 (AED 4.152). For the first half of 2025, the fund's return in JPY was 1.8%, compared to the S&P Japan BMI Liquid 35/20 Capped Index’s (the “Index”) return of 1.6%. Since inception, the fund’s return is 3.8% versus the index’s 3.2% return.
In the second quarter of 2025, a dividend of JPY 0.3467 was announced for the Chimera S&P Japan UCITS ETF, yielding 0.2% based on the end-of-June NAV. The ex-dividend date was 30 June 2025, and the payment date is set for 21 July 2025.
* The Fund and Index data specified in the graph are calculated since the inception of the Fund
Page 10
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 7
Investment Manager’s Report (continued)Chimera S&P Japan UCITS ETF (“the Fourth Sub-Fund”) (continued)Tracking Difference
The Fund's tracking difference in 1H2025 was 21.0 bps, of which 53.0 bps is attributed to management fees, resulting in a gross tracking difference of 74.0 bps. In 1H2025, the annualized tracking error was 49.1 bps.
2024 1H2025 ITD
Fund Return*1.9%1.8%3.8%
Index Return*1.6%1.6%3.2%
Tracking Diff (bps)35.421.058.0
Total Expense Ratio (bps)57.053.0105.0
Tracking Diff gross (bps)92.474.0163.0
Annualized Tracking Error (bps)22.049.136.8
*All returns are in base currency (JPY)
As stated under the Investment Policy of the Chimera S&P Japan UCITS ETF Supplement, it is expected, but not guaranteed, that the annual Tracking Difference (net of fees) will not exceed 2% and the annualized Tracking Error will not exceed 1% in normal market conditions.
Assets Under Management
As of 30 June 2025, the Chimera S&P Japan UCITS ETF had Assets Under Management (AUM) of JPY 570.3 million (AED 14.5 million). During the first half of 2025, the ETF witnessed no primary trading. In the secondary market, it traded for AED 2.6 million.
The S&P Japan BMI Liquid 35/20 Capped Index was rebalanced twice in the first half of 2025. Three additions and three deletions were made in the first quarter, and one addition and one deletion were made in the second quarter.
Chimera S&P Germany UCITS ETF (“the Fifth Sub-Fund”)
The Chimera S&P Germany UCITS ETF was launched on 25 September 2024. The fund replicates the S&P Germany BMI Liquid 35/20 Capped Index (Bloomberg code: SPDELCAP), which tracks the performance of the 30 biggest and most liquid stocks listed on the German Stock Exchange. The fund has one share class – Share Class D Income (Bloomberg code: GRMNY) – and dividends received by the fund are intended to be distributed semi-annually when available.
As of 30 June 2025, the fund’s NAV was EUR 1.104 (AED 4.762). For the first half of 2025, the fund's return in EUR was 18.1%, compared to the S&P Germany BMI Liquid 35/20 Capped Index’s (the “Index”) return of 17.8%. Since inception, the fund’s return is 22.9% versus the index’s 23.0% return.
During the second quarter of 2025, a dividend of EUR 0.0138 was announced for the Chimera S&P Germany UCITS ETF, translating into a dividend yield of 1.3% based on the end-of-June NAV. The ex-dividend date was 30 June 2025, and the payment date is 21 July 2025.
Page 11
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 8
Investment Manager’s Report (continued)Chimera S&P Germany UCITS ETF (“the Fifth Sub-Fund”) (continued)
* The Fund and Index data specified in the graph are calculated since the inception of the Fund Tracking Difference
The Fund's tracking difference in 1H2025 was 30.0 bps, of which 49.0 bps is attributed to management fees, resulting in a gross tracking difference of 79.0 bps. In 1H2025, the annualized tracking error was 27.1 bps.
2024 1H2025 ITD
Fund Return*4.0%18.1%22.9%
Index Return*4.4%17.8%23.0%
Tracking Diff (bps)-37.530.0-14.0
Total Expense Ratio (bps)26.349.074.5
Tracking Diff gross (bps)-11.279.060.5
Annualized Tracking Error (bps)14.427.123.5
*All returns are in base currency (EUR)
As stated under the Investment Policy of the Chimera S&P Germany UCITS ETF Supplement, it is expected, but not guaranteed, that the annual Tracking Difference (net of fees) will not exceed 2% and the annualized Tracking Error will not exceed 1% in normal market conditions.
Assets Under Management
As of 30 June 2025, the Chimera S&P Germany UCITS ETF had Assets Under Management (AUM) of EUR 2.8 million (AED 11.9 million). During the first half of 2025, total primary trading activity was AED 3.7 million, all in redemptions. In the secondary market, the ETF traded for AED 5.5 million.
The S&P Germany BMI Liquid 35/20 Capped Index was rebalanced twice in the first half of 2025. One addition and one deletion occurred in the first quarter, and two additions and two deletions occurred in the second quarter.
Date: 16 July 2025
Page 12
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 9
Statement of Financial PositionChimera S&PUAEUCITS ETFChimera S&PUAEUCITS ETFChimera S&PPakistanUCITS ETFChimera S&PPakistanUCITS ETFAs at30 June2025As at31 December2024As at30 June2025As at31 December2024Notes AED AED PKR PKRAssets
Cash and cash equivalents63,723,2152,883,67021,884,05621,901,444
Financial assets at fair value through profit or loss:
Transferable securities3159,368,831141,162,125672,803,414638,270,579
Total assets163,092,046144,045,795694,687,470660,172,023
Liabilities
Accrued Management fees10(397,826)(353,521)(1,746,335)(1,443,025)
Distributions Payable(3,012,800)(2,293,200)––
Total liabilities(3,410,626)(2,646,721)(1,746,335)(1,443,025)
Net assets attributable to holders of
redeemable participating shares14159,681,420141,399,074692,941,135658,728,998
Number of redeemable participating shares
Class A Accumulating Shares4500,000500,000––
Class D Distributing Shares428,000,00028,000,0001,000,0001,000,000
Net asset value per share attributable to holders of redeemable participating shares
Class A Accumulating Shares146.4805.632––
Class D Distributing Shares145.5874.949692.941658.729
The accompanying notes form an integral part of these financial statements.
Page 13
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 10
Statement of Financial Position (continued)Chimera JPMorgan UAEBondUCITS ETFChimera JPMorgan UAEBondUCITS ETFChimera S&PJapanUCITS ETFChimera S&PJapanUCITS ETFAs at30 June2025As at31 December2024As at30 June2025As at31 December2024Notes USD USD JPY JPYAssets
Cash and cash equivalents64,7876,9025,840,8872,789,390
Financial assets at fair value through profit or loss:
Transferable securities35,049,8595,038,963566,686,305558,730,611
Dividends receivable217142423,74092,619
Interest income receivable58,26255,879––
Total assets5,113,1255,101,886572,950,932561,612,620
Liabilities
Accrued Management fees10(6,705)(7,016)(1,398,519)(1,541,148)
Distributions Payable––(1,213,449)–
Total liabilities(6,705)(7,016)(2,611,968)(1,541,148)
Net assets attributable to holders of
redeemable participating shares145,106,4205,094,870570,338,964560,071,472
Number of redeemable participating shares
Class D Distributing Shares45,000,0005,000,0003,500,0003,500,000
Net asset value per share attributable to holders of redeemable participating shares
Class D Distributing Shares141.0211.019162.954160.020
The accompanying notes form an integral part of these financial statements.
Page 14
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 11
Statement of Financial Position (continued)Chimera S&PGermanyUCITS ETFChimera S&PGermanyUCITS ETFAs at30 June2025As at31 December2024
NotesEUREUR
Assets
Cash and cash equivalents648,10512,922
Financial assets at fair value through profit or loss:
Transferable securities32,754,6903,269,095
Total assets2,802,7953,282,017
Liabilities
Accrued Management fees10(7,166)(8,486)
Distributions Payable(34,500)–
Total liabilities(41,666)(8,486)
Net assets attributable to holders of
redeemable participating shares142,761,1293,273,531
Number of redeemable participating shares
Class D Income Shares42,500,0003,500,000
Net asset value per share attributable to holders of redeemable participating shares
Class D Income Shares141.1040.935
The accompanying notes form an integral part of these financial statements.
Page 15
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 12
Statement of Comprehensive IncomeChimera S&PUAEUCITS ETFChimera S&PUAEUCITS ETFChimera S&PPakistanUCITS ETFChimera S&PPakistanUCITS ETFFinancial Period1 January 2025to 30 June 2025Financial Period1 January 2024to 30 June 2024Financial Period1 January 2025to 30 June 2025Financial Period1 January 2024to 30 June 2024
AED AEDPKRPKR
Income
Dividend income75,902,1385,279,66720,142,18018,439,464
Net gains/(losses) on financial assets at fair
value through profit or loss516,123,022(9,093,077)40,359,30184,084,729
Total investment income/(expense)22,025,160(3,813,410)60,501,481102,524,193
Operating expenses
Management fees8,10(730,014)(614,162)(3,220,387)(2,033,465)
Capital gains taxes––(7,083,057)–
Total operating expenses(730,014)(614,162)(10,303,444)(2,033,465)
Net income/(expense)21,295,146(4,427,572)50,198,037100,490,728
Finance costsDistributions to holders of redeemable
participating shares16(3,012,800)(2,732,800)(15,985,900)–
Total finance costs(3,012,800)(2,732,800)(15,985,900)–
Profit/(loss) for the financial period/year
before tax18,282,346(7,160,372)34,212,137100,490,728
Increase/(decrease) in net assets resultingfrom operations attributable to holders of
redeemable participating shares18,282,346(7,160,372)34,212,137100,490,728
Gains and losses arose solely from continuing investment activities. There were no gains or losses other than those dealt with in the Statement of Comprehensive Income.
The accompanying notes form an integral part of these financial statements.
Page 16
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 13
Statement of Comprehensive Income (continued)Chimera JPMorgan UAEBondUCITS ETFChimera JPMorgan UAEBondUCITS ETFChimera S&PJapanUCITS ETFChimera S&PJapanUCITS ETFFinancial Period1 January 2025to 30 June 2025Financial Periodfrom25 March 2024to 30 June 2024Financial Period1 January 2025to 30 June 2025Financial Periodfrom28 May 2024to 30 June 2024
USD USDJPYJPY
Income
Interest income125,70378,917––
Dividend income71,451–5,331,95424,172
Net gains/(losses) on financial assets at fair
value through profit or loss568,361(65,191)8,824,92316,754,387
Other income2084––
Total investment income195,53513,81014,156,87716,778,559
Operating expenses
Management fees8,10(12,485)(8,152)(2,675,935)(786,320)
Total operating expenses(12,485)(8,152)(2,675,935)(786,320)
Net income183,0505,65811,480,94215,992,239
Finance costsDistributions to holders of redeemable
participating shares16(171,500)–(1,213,450)–
Interest expense–(107)––
Total finance costs(171,500)(107)(1,213,450)–
Profit for the financial period before tax11,5505,55110,267,49215,992,239
Increase in net assets resulting fromoperations attributable to holders of
redeemable participating shares11,5505,55110,267,49215,992,239
Gains and losses arose solely from continuing investment activities. There were no gains or losses other than those dealt with in the Statement of Comprehensive Income.
The accompanying notes form an integral part of these financial statements.
Page 17
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 14
Statement of Comprehensive Income (continued)Chimera S&PGermanyUCITS ETF*Financial Period1 January 2025to 30 June 2025EURIncome
Dividend income755,499
Net gains on financial assets at fair value
through profit or loss5457,850
Total investment income 513,349 Operating expenses
Management fees8,10(13,708)
Other operating expenses (43)
Total operating expenses (13,751) Net income 499,598
Finance costsDistributions to holders of redeemable
participating shares16(34,500)
Total finance costs (34,500)
Profit for the financial period before tax 465,098 Increase in net assets resulting from
operations attributable to holders ofredeemable participating shares 465,098*Please refer to note 20. Comparative information.
Gains and losses arose solely from continuing investment activities. There were no gains or losses other than those dealt with in the Statement of Comprehensive Income.
The accompanying notes form an integral part of these financial statements.
Page 18
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 15
Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares
Chimera S&PUAEUCITS ETFChimera S&PUAEUCITS ETFChimera S&PPakistanUCITS ETFChimera S&PPakistanUCITS ETFFinancial Period1 January 2025to 30 June 2025Financial Period1 January 2024to 30 June 2024Financial Period1 January 2025to 30 June 2025Financial Period1 January 2024to 30 June 2024
AED AEDPKRPKR
Net assets attributable to holders of redeemable participating shares at
beginning of the financial period141,399,074125,749,452658,728,998366,562,034
Increase/(decrease) in net assets resulting from operations attributable to holders of
redeemable participating shares18,282,346(7,160,372)34,212,137100,490,728
Issue of redeemable participating shares – – – – Increase in net assets resulting from share
transactions––––
Net assets attributable to holders ofredeemable participating shares at end of
the financial period159,681,420118,589,080692,941,135467,052,762
The accompanying notes form an integral part of these financial statements.
Page 19
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 16
Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares (continued) Chimera JP
Morgan UAEBondUCITS ETFChimera JPMorgan UAEBondUCITS ETFChimera S&PJapanUCITS ETFChimera S&PJapanUCITS ETFFinancial Period1 January 2025to 30 June 2025Financial Periodfrom25 March 2024to 30 June 2024Financial Period1 January 2025to 30 June 2025Financial Periodfrom28 May 2024to 30 June 2024
USD USDJPYJPY
Net assets attributable to holders of redeemable participating shares at
beginning of the financial period5,094,870–560,071,472–
Increase in net assets resulting from operations attributable to holders of
redeemable participating shares11,5505,55110,267,49215,992,239
Issue of redeemable participating shares–6,500,000–942,000,000
Redemption of redeemable participating
shares–(496,339)–(79,337,500)
Increase in net assets resulting from share
transactions–6,003,661–862,662,500
Net assets attributable to holders of redeemable participating shares at end of
the financial period5,106,4206,009,212570,338,964878,654,739
The accompanying notes form an integral part of these financial statements.
Page 20
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 17
Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares (continued) Chimera S&P
GermanyUCITS ETF*Financial Period1 January 2025to 30 June 2025EUR
Net assets attributable to holders of redeemable participating shares at
beginning of the financial period 3,273,531 Increase in net assets resulting from operations attributable to holders of redeemable participating shares 465,098 Issue of redeemable participating shares – Redemption of redeemable participating shares (977,500)
Decrease in net assets resulting from share transactions (977,500)
Net assets attributable to holders of
redeemable participating shares at end of the financial period 2,761,129
*Please refer to note 20. Comparative information.
The accompanying notes form an integral part of these financial statements.
Page 21
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 18
Statement of Cash FlowsChimera S&PUAEUCITS ETFChimera S&PUAEUCITS ETFChimera S&PPakistanUCITS ETFChimera S&PPakistanUCITS ETFFinancial Period1 January 2025to 30 June 2025Financial Period1 January 2024to 30 June 2024Financial Period1 January 2025to 30 June 2025Financial Period1 January 2024to 30 June 2024
AED AEDPKRPKR
Cash flows from operating activities
Proceeds from sale of investments8,831,0349,395,266164,915,65156,999,909
Purchase of investments(10,914,717)(11,393,308)(166,172,242)(44,088,216)
Interest income received – – – –
Dividend income received5,902,1385,279,66720,142,18018,439,464
Operating expenses paid(685,710)(614,369)(2,917,077)(1,747,973)
Net cash inflow from operating activities3,132,7452,667,25615,968,51229,603,184
Cash flows from financing activities Distributions paid to holders of redeemable
participating shares16(2,293,200)(1,996,400)(15,985,900)–
Net cash outflow from financing activities(2,293,200)(1,996,400)(15,985,900)–
Net increase/(decrease) in cash and cash
equivalents839,545670,856(17,388)29,603,184
Cash and cash equivalents at beginning of
financial period2,883,6702,520,77921,901,4442,747,144
Cash and cash equivalents at end of the
financial period63,723,2153,191,63521,884,05632,350,328
The accompanying notes form an integral part of these financial statements.
Page 22
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 19
Statement of Cash Flows (continued)Chimera JPMorgan UAEBondUCITS ETFChimera JPMorgan UAEBondUCITS ETFChimera S&PJapanUCITS ETFChimera S&PJapanUCITS ETFFinancial Period1 January 2025to 30 June 2025Financial Periodfrom25 March 2024to 30 June 2024Financial Period1 January 2025to 30 June 2025Financial Periodfrom28 May 2024to 30 June 2024
USD USDJPYJPY
Cash flows from operating activities
Proceeds from sale of investments12,119,9671,027,20546,002,94713,292,837
Purchase of investments1(2,056,831)(6,992,299)(45,133,718)(10,042,415)
Interest income received117,6695,139––
Dividend income received1,376–5,000,833–
Operating expenses paid(12,796)84(2,818,564)–
Net cash inflow/(outflow) from operating
activities169,385(5,959,871)3,051,4983,250,422
Cash flows from financing activities Distributions paid to holders of redeemable
participating shares16(171,500)–(1)–
Interest expense paid–(107)––
Amounts received on issue of redeemable
participating shares1–6,500,000––
Amounts paid on redemption of redeemable
participating shares1–(496,339)––
Net cash (outflow)/inflow from financing
activities(171,500)6,003,554(1)–
Net (decrease)/increase in cash and cash
equivalents(2,115)43,6833,051,4973,250,422
Cash and cash equivalents at beginning of
financial period6,902–2,789,390–
Cash and cash equivalents at end of the
financial period64,78743,6835,840,8873,250,422
1 Chimera S&P Japan UCITS ETF engaged in in-kind subscriptions and redemptions of redeemable participating shares during the prior financial period amounting to JPY 942,000,000 and JPY 79,337,500, respectively (refer to Note 4 to the financial statements for further details). All the subscriptions into and redemptions out of the Sub-Fund for the prior financial period were achieved via in-kind contribution and withdrawal of assets of the same amount representing consideration for purchase and sale of investments.
The accompanying notes form an integral part of these financial statements.
Page 23
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 20
Statement of Cash Flows (continued)Chimera S&PGermanyUCITS ETF*Financial Period1 January 2025to 30 June 2025EURCash flows from operating activitiesProceeds from sale of investments1 90,956Purchase of investments1 (96,201)Interest income received –Dividend income received 55,499Operating expenses paid (15,071)
Net cash inflow from operating activities 35,183 Cash flows from financing activities
Amounts received on issue of redeemable participating shares1 –
Net cash inflow from financing activities – Net increase in cash and cash equivalents 35,183 Cash and cash equivalents at beginning of financial period 12,922
Foreign exchange movement arising from aggregation –
Cash and cash equivalents at end of thefinancial period 6 48,105Bank overdraft at end of the financialperiod –*Please refer to note 20. Comparative information.
1 Chimera S&P S&P Germany UCITS ETF engaged in in-kind redemptions of redeemable participating shares during the financial period amounting to EUR 977,500 (refer to Notes 4 of the financial statements for further details). All redemptions out of the Sub- Fund for the financial period, were achieved via in kind withdrawal of assets of the same amount representing consideration for sale of investments.
The accompanying notes form an integral part of these financial statements.
Page 24
Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2025 to 30 June 2025Notes to the Unaudited Financial Statements21
1. Organisation
Chimera UCITS ICAV (the “ICAV’’) is an Irish collective asset-management vehicle registered in Ireland pursuant to the Irish Collective Asset-Management Vehicles Act 2015 (the “ICAV Act”) on 21 January 2019 with registration number C188915 and was authorised by the Central Bank of Ireland (the “CBI”) on 18 November 2020 as an Undertaking for Collective Investment in Transferable Securities (“UCITS”) under the provisions of the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011, (as amended) (the “UCITS Regulations”) and the Central Bank (Supervision and Enforcement) Act 2013 (Section 48(1)) (Undertakings for Collective Investment in Transferable Securities) Regulations 2019 (the “Central Bank UCITS Regulations”).
The ICAV is structured as an umbrella fund with segregated liability between Funds (individually a “Sub-Fund” and collectively “Sub-Funds”). The Instrument of Incorporation provides that the ICAV may offer separate classes of shares, each representing interests in a Sub-Fund comprising a distinct portfolio of investments. In addition, each Sub-Fund may be further divided into a number of different classes within the Sub-Fund. With the prior approval of the CBI, the ICAV from time to time may create additional Sub-Funds. The creation of further share classes shall be notified to and prepared and submitted to the CBI in accordance with the CBI requirements.
As at 30 June 2025, the ICAV consisted of five Sub-Funds - Chimera S&P UAE UCITS ETF (the "Sub-Fund"), launched on 23
February 2021; Chimera S&P Pakistan UCITS ETF (the "Sub-Fund”), launched on 17 August 2023; Chimera JP Morgan UAE Bond UCITS ETF (the "Sub-Fund"), launched on 25 March 2024; Chimera S&P Japan UCITS ETF (the "Sub-Fund"), launched on 28 May 2024; and Chimera S&P Germany UCITS ETF (the "Sub-Fund"), launched on 25 September 2024.
The Sub-Funds seek to provide investors with a total return, taking into account capital and income returns, which reflects the returns of equity and bond indices called the S&P UAE BMI Liquid 20/35 Capped Index (the “Index”), the S&P Pakistan BMI Liquid 35/20 Capped Index (the "Index"), J.P. Morgan MECI UAE Investment Grade Custom Index (the "Index") , the S&P Japan BMI Liquid 35/20 Capped Index (the "Index") and the S&P Germany BMI Liquid 35/20 Capped Index (the "Index"), respectively.
The Index for Chimera S&P UAE UCITS ETF is a modified weighted total return index measuring the performance of 30 of the largest constituents of the S&P UAE BMI Index. The S&P UAE BMI Index is a leading benchmark for tracking performance of the UAE equity markets. The Index is comprised of the constituents of the S&P UAE BMI Index that meet the following eligibility requirements: (i) companies must have no more than ten non-trading days over the previous quarter; and (ii) have a three-month average daily value traded volume of at least US$ 500,000 for at least one of the two quarterly periods preceding the rebalancing reference date.
The Index for Chimera S&P UAE UCITS ETF applies a UCITS capping screen of 20/35. This is to allow the Fund, whose policy is to replicate the Index, to invest up to 20% of its net assets in individual securities with the 20% limit being raised up to 35% in the case of a single issuer were justified by exceptional market conditions which may include the dominance of a particular issuer in the relevant market. The Index provider, S&P, has set triggers in place of at 33%/19% respectively to reset levels to ensure UCITS compliance at all times.
The Index of Chimera S&P Pakistan UCITS ETF is a modified weighted total return index measuring the performance of the top 15 Pakistan domiciled companies ranked in the S&P Pakistan BMI Index. The S&P Pakistan BMI Index is a leading benchmark for tracking performance of Pakistani companies. The Index is comprised of the top 15 constituents of the S&P Pakistan BMI Index that meet the following eligibility requirements: (i) companies must have no more than ten non-trading days over the previous quarter; and (ii) have a six-month average daily value traded of at least US$200,000 for at least one of the two quarterly periods preceding the rebalancing reference date.
The Index follows a six-month average daily traded value of >= $200,000. Stocks failing to meet this level will drop out of the Index once this liquidity screen fails to be met for the six-month period preceding the rebalancing reference date.
The Index of Chimera JP Morgan UAE Bond UCITS ETF is a subset of the J.P. Morgan Middle East Composite Index (MECI) (the "Parent Index"). The Index comprises the UAE investment grade USD-denominated corporate, quasi-sovereign and sovereign bond issues. The Parent Index is a leading index tracking the performance of USD-denominated debt in the Middle East. The index constituents must have a minimum face value outstanding of US$500 million, an outstanding maturity between one and two and a half years and bond ratings of BBB- or higher by at least two out of three ratings agencies of Standard & Poor's, Moody's and Fitch.
Page 25
Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2025 to 30 June 2025Notes to the Unaudited Financial Statements (continued)22
1. Organisation (continued)
Index rebalancing occurs monthly on the last business day of each month. The Index applies a dual capping methodology, where all issuers are initially capped at 9.0%. The Index is then recalculated until all issuers are below the cap. The issuers above 4.5% are ranked, and the aggregate of these issuers must be below the 38.0% threshold, the highest ranked issuer that breaches the threshold and all remaining issuers in the index are capped at 4.5% after reweighting is applied. These reset triggers of 4.5%/9.0%/38.0% have been set by the Index Provider, JP Morgan, to ensure compliance with the UCITS diversification rules (ie. the 5/10/40 Rule) by creating a buffer below the regulatory limits.
The Index of Chimera S&P Japan UCITS ETF is modified weighted total return index measuring the performance of the top 30
Japan domiciled companies ranked in the S&P Japan BMI Index. The constituents of the S&P Japan BMI Index meet the following eligibility requirements: (i) companies must have no more than ten non-trading days over the previous quarter; and (ii) have a six-month average daily value traded of at least US$1,000,000 for at least one of the two quarterly periods preceding the rebalancing reference date.
The Index applies a UCITS capping screen of 35%/20%. This is to allow the Fund, whose policy is to replicate the Index, to invest up to 20% of its net assets in individual securities with the 20% limit being raised up to 35% in the case of a single issuer where justified by exceptional market conditions which may include the dominance of a particular issuer in the relevant market.
The Index provider, S&P, has set triggers in place at 33%/19% respectively to reset levels to ensure UCITS compliance at all times.
The Index of Chimera S&P Germany UCITS ETF is a modified weighted total return index measuring the performance of the top 30 German domiciled companies ranked in the S&P Germany Index. The constituents of the S&P Germany BMI Index meet the following eligibility requirements: (i) companies must have no more than ten non-trading days over the previous quarter; and (ii) have a six-month average daily value traded of at least US$1,000,000 for at least one of the two quarterly periods preceding the rebalancing reference date.
The Index applies a capping screen of 35%/20%. This will mean that the Sub-Fund, through investing in equity securities, may invest up to 20% of its net assets in a single security with the 20% limit being raised up to 35% in the case of a single issuer where justified by exceptional market conditions such as a material price movement impacting the weighting of that single component within the Index and necessitating a larger exposure. The Index provider, S&P, has set triggers in place at 33%/19% respectively to reset levels to ensure UCITS compliance.
In order to achieve its investment objective, the investment policy of the Sub-Funds are to invest 100% of their net assets in a portfolio of equity and bond securities that consists of the equity and bond securities of each Index. Lunate Capital Limited (the "Investment Manager"), may deviate from the 100% investment where it is, for whatever reason, not possible to buy and hold a particular Index security.
The Sub-Funds attempt to replicate, before fees and expenses, the performance of each Index. The Investment Manager will seek to do this by replicating so far as possible the investments in each Index by holding all of the securities comprising each Index in approximately the same proportion as its weighting in each Index.
The base currency of Chimera S&P UAE UCITS ETF (the “Sub-Fund”), Chimera S&P Pakistan UCITS ETF (the “Sub- Fund"), Chimera JP Morgan UAE Bond UCITS ETF (the "Sub-Fund), Chimera S&P Japan UCITS ETF (the "Sub-Fund") and Chimera S&P Germany UCITS ETF (the "Sub-Fund”) is the United Arab Emirates Dirham (“AED”), Pakistani Rupee ("PKR"), U.S.
Dollar ("USD"), Japanese Yen ("JPY") and Euro ("EUR") respectively. The base currency of the ICAV is AED. The Net Asset Value per Share will be published and settlement and dealing will be affected in the designated currency of each Class.
The shares of the active Sub-Funds are listed and admitted for trading on the following stock exchanges: Class A Accumulating Shares are listed on the Dubai Financial Market while Class D Distributing Shares are listed on Abu Dhabi Securities Exchange.
Page 26
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 Notes to the Unaudited Financial Statements (continued) 23
2. Material Accounting Policies
(a) Basis of preparation
These condensed interim report and unaudited financial statements have been prepared in accordance with IAS 34, "Interim Financial Reporting", the ICAV Act, the UCITS Regulations and the Central Bank UCITS Regulations and should be read in conjunction with the annual report and audited financial statements for the financial year ended 31 December 2024.
Selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the financial position and performance of the Sub-Fund since the last annual report and audited financial statements.
They do not include all the information required for a full set of annual financial statements prepared in accordance with International Financial Reporting Standards ("IFRS").
The condensed interim report and unaudited financial statements have been prepared on a going concern basis which assumes that the ICAV will continue in operational existence for the foreseeable future and have been prepared under the historical cost convention, as modified by the revaluation of financial assets and financial liabilities at fair value through profit or loss.
The preparation of the condensed interim report and unaudited financial statements in conformity with IFRS requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the reporting date and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management’s best knowledge of the amount, event or actions, actual results ultimately may differ from those estimates.
The Directors make estimates and assumptions concerning the future of the ICAV. The resulting accounting estimates will, by definition, seldom equal the related actual results. There are no estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities.
International Financial Reporting Standards
New and revised IFRSs applied with no material effect on the condensed financial statements
In the current period, the ICAV has applied a number of amendments to IFRS Accounting Standards and Interpretations issued by the International Accounting Standards Board (IASB) that are effective for an annual period that begins on or after 1 January 2025.
Amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates relating to Lack of Exchangeability Other than the above, there are no other significant IFRS Accounting Standards and amendments that were effective for the first time for the financial year beginning on or after 1 January 2025.
New and revised IFRSs in issue but not yet effective
The ICAV has not early adopted any new and revised IFRSs that have been issued but are not yet effective.
New and revised IFRSsEffective for annualperiods beginning onor after
Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures regarding the classification and measurement of financial instruments
1 January 2026
Amendments to IFRS 9 Financial Instruments and IFRS 7 Financial Instruments: Disclosures regarding purchase power arrangements
1 January 2026
Page 27
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 Notes to the Unaudited Financial Statements (continued) 24
2. Material Accounting Policies (continued)
(a) Basis of preparation (continued)
New and revised IFRSs in issue but not yet effective (continued) New and revised IFRSs (continued)
Effective for annualperiods beginning onor after
Annual improvements to IFRS Accounting Standards - Volume 11 The pronouncement comprises the following amendments:
IFRS 1: Hedge accounting by a first-time adopter IFRS 7: Gain or loss on derecognition
IFRS 7: Disclosure of deferred difference between fair value and transaction price
IFRS 7: Introduction and credit risk disclosures IFRS 9: Lessee derecognition of lease liabilities IFRS 9: Transaction price IFRS 10: Determination of a “de facto agent” IAS 7: Cost method1 January 2026
IFRS 18 Presentation and Disclosures in Financial Statements 1 January 2027 IFRS 19 Subsidiaries without Public Accountability: Disclosures 1 January 2027 Amendments to IFRS 10 Consolidated Financial Statements and IAS 28 Investments in Associates and Joint Ventures (2011)
Effective date deferredindefinitely. Adoptionis still permitted.
The above stated new standards and amendments are not expected to have any significant impact on the condensed financial statements of the ICAV.
There are no other applicable new standards and amendments to published standards or IFRIC interpretations that have been issued that would be expected to have a material impact on the condensed financial statements of the ICAV.
3. Fair Value
IFRS 13 ‘Fair Value Measurement' requires disclosure relating to the fair value hierarchy in which fair value measurements are categorised as assets and liabilities in the Statement of Financial Position.
The disclosures are based on a three-level fair value hierarchy for the inputs used in valuation techniques to measure fair value.
The fair value of financial assets and financial liabilities traded in an active market (such as trading securities) are based on quoted market prices at the close of trading on the reporting date.
A financial instrument is regarded as quoted in an active market if the quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing service, or regulatory agency, and those prices represent actual and regularly occurring market transactions on an arm's length basis. These instruments are included within Level 1 of the hierarchy.
The fair value of financial assets and financial liabilities that are not traded in an active market is determined by using valuation techniques. The ICAV uses a variety of methods and makes assumptions that are based on market conditions existing at the reporting date. These instruments are included within Level 2 of the hierarchy. The fair value hierarchy has the following levels:
Quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1).
Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices) (Level 2).
Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs) (Level 3).
Transfers are deemed to occur at the end of the financial period.
Page 28
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 Notes to the Unaudited Financial Statements (continued) 25
3. Fair Value (continued)
There were no transfers between levels during the financial period ended 30 June 2025 and financial year ended 31 December 2024 for the Sub-Funds.
Chimera S&P UAE UCITS ETF
Financial Assets at Fair Value through Profit or Loss As at 30 June 2025
Level 1 Level 2 Level 3 Total
AEDAEDAEDAED
Transferable securities
Equities159,368,831––159,368,831
Total159,368,831––159,368,831
Chimera S&P UAE UCITS ETF
Financial Assets at Fair Value through Profit or Loss As at 31 December 2024
Level 1 Level 2 Level 3 Total
AEDAEDAEDAED
Transferable securities
Equities141,162,125––141,162,125
Total141,162,125––141,162,125
Chimera S&P Pakistan UCITS ETF
Financial Assets at Fair Value through Profit or Loss As at 30 June 2025
Level 1 Level 2 Level 3 Total
PKRPKRPKRPKR
Transferable securities
Equities672,803,414––672,803,414
Total672,803,414––672,803,414
Chimera S&P Pakistan UCITS ETF
Financial Assets at Fair Value through Profit or Loss As at 31 December 2024
Level 1 Level 2 Level 3 Total
PKRPKRPKRPKR
Transferable securities
Equities638,270,579––638,270,579
Total638,270,579––638,270,579
Page 29
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 Notes to the Unaudited Financial Statements (continued) 26
3. Fair Value (continued)
Chimera JP Morgan UAE Bond UCITS ETF
Financial Assets at Fair Value through Profit or Loss As at 30 June 2025
Level 1 Level 2 Level 3 Total
USDUSDUSDUSD
Transferable securities
Corporate Bonds–4,266,524–4,266,524
Government Bonds–714,907–714,907
Mutual Funds68,428––68,428
Total68,4284,981,431–5,049,859
Chimera JP Morgan UAE Bond UCITS ETF
Financial Assets at Fair Value through Profit or Loss As at 31 December 2024
Level 1 Level 2 Level 3 Total
USDUSDUSDUSD
Transferable securities
Corporate Bonds–4,274,698–4,274,698
Government Bonds–699,189–699,189
Mutual Funds65,076––65,076
Total65,0764,973,887–5,038,963
Chimera S&P Japan UCITS ETF
Financial Assets at Fair Value through Profit or Loss As at 30 June 2025
Level 1 Level 2 Level 3 Total
JPYJPYJPYJPY
Transferable securities
Equities566,686,305––566,686,305
Total566,686,305––566,686,305
Chimera S&P Japan UCITS ETF
Financial Assets at Fair Value through Profit or Loss As at 31 December 2024
Level 1 Level 2 Level 3 Total
JPYJPYJPYJPY
Transferable securities
Equities558,730,611––558,730,611
Total558,730,611––558,730,611
Page 30
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 Notes to the Unaudited Financial Statements (continued) 27
3. Fair Value (continued)
Chimera S&P Germany UCITS ETF
Financial Assets at Fair Value through Profit or Loss As at 30 June 2025
Level 1 Level 2 Level 3 Total
EUREUREUREUR
Transferable securities
Equities2,754,690––2,754,690
Total2,754,690––2,754,690
Chimera S&P Germany UCITS ETF
Financial Assets at Fair Value through Profit or Loss As at 31 December 2024
Level 1 Level 2 Level 3 Total
EUREUREUREUR
Transferable securities
Equities3,269,095––3,269,095
Total3,269,095––3,269,095
Assets and liabilities not carried at fair value but for which fair value is disclosed
The ICAV’s assets and liabilities (by class) not measured at fair value at 30 June 2025 and 31 December 2024 but for which fair value is disclosed within the fair value hierarchy are considered Level 2, except for cash and cash equivalents, which are considered Level 1.
Cash and cash equivalents include cash on hand and demand deposits held with banks and brokers.
4. Share Capital
The issued share capital of the ICAV shall be not less than the currency equivalent of €2 represented by two subscriber shares of no par value and the maximum issued share capital of the ICAV shall not be more than 500 billion shares of no par value. The share capital of the ICAV shall at all times equal the Net Asset Value of the ICAV.
Subscriber shares entitle the holders to attend and vote at all meetings of the ICAV but do not entitle the holders to participate in the dividends or net assets of any Sub-Fund or of the ICAV. The holders of the subscriber shares shall have one vote for each subscriber share held.
Each of the redeemable shares entitles the Shareholder to participate equally on a pro rata basis in the dividends and net assets of a Sub-Fund attributable to the relevant Class in respect of which they are issued, save in the case of dividends declared prior to becoming a Shareholder.
The Directors reserve the right to predesignate any class of shares from time to time, provided that Shareholders in that class shall first have been notified by the ICAV thirty calendar days in advance that the shares will be predesignated and shall have been given the opportunity to have their shares redeemed by the ICAV, except that this requirement shall not apply where the Directors predesignate shares in issue in order to facilitate the creation of an additional class of shares.
Page 31
Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2025 to 30 June 2025Notes to the Unaudited Financial Statements (continued)28
4. Share Capital (continued)
Each of the redeemable shares entitles the holder to attend and vote at meetings of the ICAV and of the relevant Sub-Fund represented by those shares. No class of shares confers on the holder thereof any preferential or pre-emptive rights or any rights to participate in the profits and dividends of any other class of shares or any voting rights in relation to matters relating solely to any other class of shares.
Any resolution to alter the class rights of the shares requires the approval of three quarters of the holders of the shares represented or present and voting at a general meeting duly convened in accordance with the Instrument of Incorporation.
The following table shows the share class movement during the financial period ended 30 June 2025 and financial year ended 31
December 2024:Chimera S&P UAE UCITS ETFFinancial Period1 January 2025to 30 June 2025Financial Period1 January 2024to 31 December 2024Class A Accumulating Shares
Balance at beginning of financial period/year500,000500,000
Balance at end of financial period/year500,000500,000
Class D Distributing Shares
Balance at beginning of financial period/year28,000,00028,000,000
Balance at end of financial period/year28,000,00028,000,000
Chimera S&P Pakistan UCITS ETF Financial Period
1 January 2025to 30 June 2025Financial Period1 January 2024to 31 December 2024Class D Distributing Shares
Balance at beginning of financial period/year1,000,0001,000,000
Balance at end of financial period/year1,000,0001,000,000
Chimera JP Morgan UAE Bond UCITS ETF Financial Period
1 January 2025to 30 June 2025Financial Period25 March 2024to 31 December 2024Class D Distributing Shares
Balance at beginning of financial period5,000,000–
Shares issued–6,500,000
Shares redeemed–(1,500,000)
Balance at end of financial period5,000,0005,000,000
Page 32
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 Notes to the Unaudited Financial Statements (continued) 29
4. Share Capital (continued)
Chimera S&P Japan UCITS ETFFinancial Period1 January 2025to 30 June 2025Financial Period28 May 2024to 31 December 2024Class D Distributing Shares
Balance at beginning of financial period3,500,000–
Shares issued^–6,000,000
Shares redeemed^–(2,500,000)
Balance at end of financial period3,500,0003,500,000
Chimera S&P Germany UCITS ETFFinancial Period1 January 2025to 30 June 2025Financial Period25 September 2024to 31 December 2024Class D Income Shares
Balance at beginning of financial period3,500,000–
Shares issued^–3,500,000
Shares redeemed^(1,000,000)–
Balance at end of financial period2,500,0003,500,000
^ In respect of Chimera S&P Japan UCITS ETF, relates to in-kind subscriptions of 6,000,000 shares valued at JPY 942,000,000 and in-kind redemptions of 2,500,000 valued at JPY 394,853,000 for Class D Distributing Shares for the prior financial period; and for Chimera S&P Germany UCITS ETF, relates to in-kind subscriptions of 3,500,000 shares valued at EUR 3,146,500 for Class D Distributing Shares for the prior financial period and in-kind redemptions of 1,000,000 shares valued at EUR 977,500 for Class D Distributing Shares for the financial period.
5. Net (Losses)/Gains on Financial Assets at Fair Value Through Profit or Loss
Chimera S&P UAEUCITS ETFChimera S&P PakistanUCITS ETFFinancial Period1 January 2025to 30 June 2025Financial Period1 January 2024to 30 June 2024Financial Period1 January 2025to 30 June 2025Financial Period1 January 2024to 30 June 2024
AED AEDPKRPKR
Net realised gains/(losses) on sale of
financial assets at FVTPL585,862(920,663)55,956,49913,005,596
Net realised (losses)/gains on other currency(4)224–(241)
Net change in unrealisedappreciation/(depreciation) on financial
assets at FVTPL15,537,164(8,172,638)(15,597,528)71,079,380
Other currency gains/(losses)––330(6)
Net gains/(losses) on financial assets at
fair value through profit or loss16,123,022(9,093,077)40,359,30184,084,729
Page 33
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 Notes to the Unaudited Financial Statements (continued) 30
5. Net (Losses)/Gains on Financial Assets at Fair Value Through Profit or Loss (continued) Chimera JP Morgan UAE Bond
UCITS ETFChimera S&P JapanUCITS ETFFinancial Period1 January 2025to 30 June 2025Financial Period25 March 2024to 30 June 2024Financial Period1 January 2025to 30 June 2025Financial Period28 May 2024to 30 June 2024
USD USDJPYJPY
Net realised (losses)/gains on sale of
financial assets at FVTPL(5,246)(23,631)(7,291,946)389,816
Net change in unrealisedappreciation/(depreciation) on financial
assets at FVTPL73,605(41,559)16,116,86916,364,571
Other currency gains/(losses)2(1)––
Net gains/(losses) on financial assets at
fair value through profit or loss68,361(65,191)8,824,92316,754,387
Chimera S&PGermanyUCITS ETF*Financial Period1 January 2025to 30 June 2025EUR
Net realised gains on sale of financial assets at FVTPL 78,590
Net change in unrealised appreciation on financial assets at FVTPL 379,260
Net gains on financial assets at fair value through profit or loss 457,850
*Please refer to note 20. Comparative information.
6. Cash and Cash Equivalents
Cash and cash equivalents held at the financial period ended 30 June 2025 and for the financial year ended 31 December 2024 are held with, The Bank of New York Mellon SA/NV, Dublin Branch (the “Depositary”).
The Standard & Poor’s long term credit rating of the Depositary was AA- at 30 June 2025 (31 December 2024: AA-).
7. Taxation
Under current law and practice, the ICAV qualifies as an investment undertaking as defined in Section 739B of the Taxes Consolidation Act, 1997, as amended. On that basis, it is not chargeable to Irish tax on its income or gains.
However, Irish tax may arise on the happening of a “chargeable event”. A chargeable event includes any distribution payments to Shareholders, any encashment, redemption, cancellation or transfer of Shares and the holding of Shares at the end of each eight year period beginning with the acquisition of such Shares.
No Irish tax will arise on the Sub-Funds in respect of chargeable events in respect of:
(a) transactions by a Shareholder who is neither Irish resident nor ordinarily resident in Ireland for tax purposes at the time of the chargeable event, provided the appropriate valid declarations, in accordance with the provisions of the Taxes Consolidation Act, 1997, as amended, are held by the Sub-Funds or the Sub-Funds have been authorised by the Irish Revenue to make gross payments in the absence of appropriate declarations; and
Page 34
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 Notes to the Unaudited Financial Statements (continued) 31
7. Taxation (continued)
(b) transactions by certain exempted Irish resident Shareholders who have provided the relevant Sub-Fund with the necessary signed statutory declarations.
Dividends, interest and capital gains, (if any), received on investments made by the Sub-Funds may be subject to taxes imposed by the country from which the investment income/gains are received, and such taxes may not be recoverable by the Sub-Funds or its Shareholders.
In respect of Chimera S&P Pakistan UCITS ETF, the Sub-Fund is subject to Pakistani capital gains taxes. In the financial period, capital gains tax payments in the amount of PKR 7,083,057 (30 June 2024: PKR Nil) were incurred as disclosed in the Statement of Comprehensive Income. It is likely that any future disposals of financial assets at FVTPL at a gain, will result in future capital gains tax exposures. As this tax exposure is not readily identifiable at this time, this has not been accrued within the NAV of the Sub-Fund.
In the Statement of Comprehensive Income, the figures for dividend income incorporate withholding taxes for Chimera S&P Pakistan UCITS ETF in the amount of PKR 3,300,640 (30 June 2024: PKR 2,706,749), Chimera S&P Japan UCITS ETF in the amount of JPY 954,399 (30 June 2024: JPY 4,266) and Chimera S&P Germany UCITS ETF in the amount of EUR 14,665.
8. Expenses
The ICAV shall pay to the Manager out of the Sub-Funds’ assets an annual Management Fee of 1% of equity Sub-Funds' and 0.5% of bond Sub-Fund's daily Net Asset Values. The Manager will retain a fee for its remuneration (in respect of the provision of management services and such other services as have been agreed with the Manager, including the provision of company secretarial services, MLRO services and the maintenance of the ICAV’s beneficial ownership register) out of the Management Fee and any reasonable and properly vouched expenses as well as extraordinary expenses outside the ordinary course of business where agreed in advance with the ICAV and shall further discharge all fees and expenses related to the Sub-Funds.
The following expenses will be discharged by the Manager out of the Management Fee: fees payable to the Depositary, Administrator, Investment Manager, Global Distributor and Directors and all operational expenses, including but not limited to, expenses and reasonable out of pocket expenses of the Depositary, Administrator, Investment Manager, Global Distributor and Directors, the costs of maintaining the Sub-Funds and any registration of the Funds with any governmental or regulatory authority; the costs of registering a Fund in other jurisdictions or with any stock exchange, filing fees; preparation, printing, and posting of the Prospectus and other prospectuses, sales literature and reports to shareholders, regulatory fees of the CBI and other governmental agencies; insurance premiums; fees and expenses for legal, audit, other professionals and other services; levies incurred in connection with acquiring or disposing of Investments or in connection with creation and redemption transactions including any fees and expenses payable as a result of entering into FDI transactions or arising from investment in collective investment schemes (including, without limitation, any fees, charges, taxes, levies or expenses related to the purchase or sale of an amount of any currency, or the patriation or repatriation of any security or other asset, or related to the execution of portfolio transactions or any creation or redemption transactions); fees and expenses incurred in connection with securities lending; paying for sublicensing fees related to each Fund's Index and any distribution fees or expenses but excluding interest, taxes, brokerage commissions and other expenses connected with execution of portfolio transactions, and extraordinary expenses. Where the above expenses exceed the Management Fees, the Investment Manager will discharge any such expenses out of its own assets.The fees and expenses relating to the establishment and approval of the Sub-Funds, including the fees of the ICAV’s professional advisers, the fees and expenses incurred with respect to registering the shares of the Sub-Funds for sale in various markets, and the expenses associated with the issue of shares, including the costs incurred in connection with the preparation and publication of the Supplement, and all legal and printing costs will be borne by the Investment Manager.
9. Transaction Costs
Transaction costs are incremental costs that are directly attributable to the acquisition, issue or disposal of a financial asset or financial liability. An incremental cost is one that would not have been incurred if the entity had not acquired, issued or disposed of the financial instrument. When a financial asset or financial liability is recognised initially, an entity shall measure it at its fair value through profit or loss plus, transaction costs that are directly attributable to the acquisition or issue of the financial asset or financial liability.
Page 35
Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2025 to 30 June 2025Notes to the Unaudited Financial Statements (continued)32
9. Transaction Costs (continued)
Transaction costs on purchases and sales of equities are borne by the Sub-Funds and included within net gains/(losses) on investments in the Statement of Comprehensive Income. Purchases and sales transaction costs include identifiable brokerage charges, commissions, transaction related taxes and other market charges.
Transactions costs incurred on purchases and sales during the financial periods ended 30 June 2025 and 30 June 2024 were as follows:
Sub-Fund Base Currency Financial period Ended30 June 2025Financial period Ended30 June 2024
Chimera S&P UAE UCITS ETF AED18,14016,626
Chimera S&P Pakistan UCITS ETF PKR846,804252,803
Chimera S&P JP Morgan UAE Bond UCITS ETF USD Nil Nil
Chimera S&P Japan UCITS JPY91,13849,805
Chimera S&P Germany UCITS ETF EUR 108 Nil
10. Related Parties transactions
According to IAS 24 Related Parties, parties are considered to be related if one party has the ability to control the other party or exercise significant influence over the other party in making financial or operational decisions or is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. The following related party relationships and transactions have been identified. The Directors, Manager and the Investment Manager are considered as key management personnel for this purpose.
The Manager is entitled to receive out of the Sub-Funds’ assets an annual Management Fee of 1% of the Sub-Funds’ daily Net Asset Values. The Manager will retain a fee for its remuneration (in respect of the provision of management services and such other services as have been agreed with the Manager, including the provision of company secretarial services, MLRO services and the maintenance of the ICAV’s beneficial ownership register). The Manager is also entitled to be reimbursed for any reasonable and properly vouched expenses (the “Manager’s Expenses”) as well as extraordinary expenses outside the ordinary course of business where agreed in advance with the ICAV.
Total fees earned by the Manager during the financial period ended 30 June 2025 amounted to EUR 30,023 (30 June 2024: EUR 28,333) of which EUR 30,023 was outstanding at (31 December 2024: EUR 67,746).
The emoluments of all the Directors who are entitled to remuneration for their services as Directors in respect of any twelve-month accounting period shall not exceed €80,000 or such higher amount as may be approved by the Board of Directors. The Directors are also entitled to be reimbursed for their reasonable out of pocket expenses incurred in discharging their duties as Directors. Such fees and expenses are paid out of the annual management fee paid to the Manager.
Directors’ fees incurred during the financial periods ended 30 June 2025 amounted to EUR 20,000 (30 June 2024: EUR 20,000) of which EUR Nil was outstanding at 31 December 2024 (31 December 2024: EUR Nil). Directors' fees were earned by 2 of the Independent Directors. None of the Directors who are employees of the Investment Manager or its related entity earned fees during the financial period ended 30 June 2025 and 30 June 2024.
The Investment Manager earned fees for investment management services of AED 947,649 during the financial period ended 30
June 2025 (30 June 2024: AED 689,880) of which AED 482,631 was outstanding at 31 December 2024: AED 468,910). As with the other expenses, the fees are paid out of the annual management fee paid to the Manager.
At 30 June 2025, the ICAV had four Authorised Participants, Arqaam Capital, BHM Capital Financial Services PrJSC, EFG Hermes UAE L.L.C and International Securities L.L.C, through which share transactions are conducted on the primary market.
International Securities L.L.C is a related party to the Investment Manager.
At 30 June 2025, the 2 Subscriber shares were held on behalf on the ICAV by the Investment Manager.
Page 36
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 Notes to the Unaudited Financial Statements (continued) 33
11. Contingent Liabilities and Commitments
Except for the matters as disclosed in Note 7, there were no other contingent liabilities or commitments as at the financial periods ended 30 June 2025 and 30 June 2024.
12. Segregation of Liability
The ICAV is an umbrella fund with segregated liability between Sub-Funds and each Sub-Fund may comprise one or more classes of shares in the ICAV. The Directors may, from time to time, upon the prior approval of the CBI, establish further Sub- Funds by the issue of one or more separate classes of shares on such terms as the Directors may resolve. The Directors may, from time to time, in accordance with the requirements of the CBI, establish one or more separate classes of shares within each Sub-Fund on such terms as the Directors may resolve.
13. Umbrella Cash Collection Accounts
The CBI published the Central Bank (Supervision and Enforcement) Act 2013 (Section 48(1)) Investor Money Regulations 2015 for Fund Service Providers (the “Investor Money Regulations” or “IMR”) in March 2015 (effective from 1 July 2016). The Management Company, together with the Administrator implemented procedures in relation to the way subscription and redemption monies are channeled to and from the ICAV. These transactions are channeled through an umbrella cash collection account in the name of the ICAV. Pending issue of the shares and/or payment of subscription proceeds to an account in the name of the ICAV or the relevant Sub-Funds, and pending payment of redemption proceeds or distributions, the relevant investor will be an unsecured creditor of the relevant Sub-Fund in respect of amounts paid by or due to it. As at 30 June 2025 and 31
December 2024, there was no IMR related balance included within cash and cash equivalents in the Statement of Financial Position.
14. Net Asset Value Attributable to Holders of Redeemable Participating Shares
Chimera S&P UAE UCITS ETFAs at30 June 2025As at31 December 2024As at31 December 2023Total Net Asset ValueClass A Accumulating Shares AED 3,239,950 AED 2,815,871 AED 2,406,435
Class D Distributing Shares AED 156,441,471 AED 138,583,204 AED 123,343,017
Net Asset Value per ShareClass A Accumulating Shares AED 6.480 AED 5.632 AED 4.813Class D Distributing Shares AED 5.587 AED 4.949 AED 4.405Chimera S&P Pakistan UCITS ETFAs at30 June 2025As at31 December 2024As at31 December 2023Total Net Asset Value
Class D Distributing Shares PKR 692,941,135 PKR 658,728,998 PKR 366,562,034 Net Asset Value per Share
Class D Distributing Shares PKR 692.941 PKR 658.729 PKR 366.562
Page 37
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 Notes to the Unaudited Financial Statements (continued) 34
14. Net Asset Value Attributable to Holders of Redeemable Participating Shares (continued) Chimera JP Morgan UAE Bond UCITS ETF
As at30 June 2025As at31 December 2024As at31 December 2023Total Net Asset Value
Class D Distributing Shares USD 5,106,420 USD 5,094,870 USD – Net Asset Value per Share
Class D Distributing Shares USD 1.021 USD 1.019 USD – Chimera S&P Japan UCITS ETF
As at30 June 2025As at31 December 2024As at31 December 2023Total Net Asset Value
Class D Distributing Shares JPY 570,338,964 JPY 560,071,472 JPY – Net Asset Value per Share
Class D Distributing Shares JPY 162.954 JPY 160.020 JPY – Chimera S&P Germany UCITS ETF
As at30 June 2025As at31 December 2024As at31 December 2023Total Net Asset Value
Class D Income Shares EUR 2,761,129 EUR 3,273,531 EUR – Net Asset Value per Share
Class D Income Shares EUR 1.104 EUR 0.935 EUR – 15. Soft Commissions and Directed Brokerage Arrangements
There were no soft commissions and directed brokerage arrangements entered into by the ICAV and the Sub-Funds during the financial periods ended 30 June 2025 and 30 June 2024.
Page 38
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 Notes to the Unaudited Financial Statements (continued) 35
16. Distributions
Distributions from Chimera S&P UAE UCITS ETF per share class during the financial periods ended 30 June 2025 and 30 June 2024 were as follows:
Financial period ended 30 June 2025Chimera S&P UAE UCITS ETF
Share Class Ex Date Pay Date Dividend per Amount Redeemable Participating
Share AED
Class D Distributing Shares 30 June 2025 21 July20250.10763,012,800
Financial period ended 30 June 2024
Share Class Ex Date Pay Date Dividend per Amount Redeemable Participating
Share AED
Class D Distributing Shares 14 June 2024 10 July20240.09762,732,800
Financial period ended 30 June 2025Chimera S&P Pakistan UCITS ETF
Share Class Ex Date Pay Date Dividend per Amount Redeemable Participating
Share PKR
Class D Distributing Shares 13 February 2025 07 March202515.985915,985,900
Financial period ended 30 June 2025Chimera JP Morgan UAE Bond UCITS ETF
Share Class Ex Date Pay Date Dividend per Amount Redeemable Participating
Share USD
Class D Distributing Shares 03 February 2025 17 February20250.0343171,500
Financial period ended 30 June 2025Chimera S&P Japan UCITS ETF
Share Class Ex Date Pay Date Dividend per Amount Redeemable Participating
Share JPY
Class D Distributing Shares 30 June 2025 21 July20250.34671,213,450
Financial period ended 30 June 2025Chimera S&P Germany UCITS ETF
Share Class Ex Date Pay Date Dividend per Amount Redeemable Participating
Share EUR
Class D Distributing Shares 30 June 2025 21 July20250.013834,500
Page 39
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 Notes to the Unaudited Financial Statements (continued) 36
17. Exchange Rates
The following average exchange rate was used to convert certain expense payments to AED:
Financial period ended30 June 2025Financial year ended31 December 2024Financial year ended30 June 2024
EUR0.2493930.2546930.251775
JPY40.37792941.34460041.365912
PKR76.38215975.84590475.966613
USD0.2722650.2722610.272269
18. Efficient Portfolio Management
The Investment Manager may, on behalf of the Sub-Funds and subject to the conditions and within the limits laid down by the Central Bank of Ireland, employ techniques and instruments relating to transferable securities and money market instruments for efficient portfolio management purposes in accordance with the investment strategy of the Sub-Funds.
Transactions for the purposes of efficient portfolio management may be undertaken with a view to achieving the reduction of risk, the reduction of cost, or the generation of additional capital or income for the Sub-Funds with an appropriate level of risk and taking into account the risk profile of each Sub-Fund. Techniques and instruments used for efficient portfolio management purposes may include Investments in financial derivative instruments (“FDI”) including futures, options and swaps, the entry into securities lending transactions, repurchase and/or reverse repurchase agreements. All revenues arising from efficient portfolio management activities, net of direct and indirect operational costs will be retained by the Sub-Funds and recognised in the Statement of Comprehensive Income.
The Sub-Funds did not engage in any efficient portfolio management activities during the financial periods ended 30 June 2025 and 30 June 2024.
19. Transactions with Connected Persons
Regulation 43 (1) of the Central Bank UCITS Regulations “Restrictions of transactions with connected persons” states that “A responsible person shall ensure that any transaction between a UCITS and a connected person is conducted a) at arm’s length; and b) in the best interest of the shareholders of the UCITS”.
As required under the Central Bank UCITS Regulation 81 (4), the Manager, as responsible person, has confirmed to the Board of Directors of the ICAV that it is satisfied that there are arrangements in place, evidenced by written procedures, to ensure that obligations set out in Regulation 43(1) are applied to all transactions with connected persons; and all transactions with connected persons that were entered into during the financial period to which the report relates, complied with the obligations that are prescribed by Regulation 43(1).
20. Comparative information
Chimera S&P Germany UCITS ETF was launched on 25 September 2024. Therefore, there are no comparatives for the financial period ended 30 June 2024 for the Statement of Comprehensive Income, Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares, Statement of Cash Flows, Net (Losses)/Gains on Financial Assets at Fair Value Through Profit or Loss Note and Transaction Costs.
21. Significant Events during the Financial Period
The addresses of the Depositary and Administrator of the ICAV were changed, effective 3 June 2025, as detailed in the "Directors and Other Information" section of the interim report and accounts.
There have been no other significant subsequent events after the financial period end that require disclosure in the financial statements.
Page 40
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 Notes to the Unaudited Financial Statements (continued) 37
22. Subsequent Events after the Financial Period End
Boreas Solactive Quantum Computing UCITS ETF was approved by the Central Bank of Ireland as a Sub-Fund of the ICAV, effective 25 July 2025.
There have been no other significant subsequent events after the financial period end that require disclosure in the financial statements.
23. Valuation Point
The effective valuation point and prices used for the valuation of investments was 30 June 2025, being the last business day in the financial period for the relevant markets.
24. Whistleblowing Policy
The ICAV has adopted a whistleblowing policy pursuant to the Protected Disclosures Act 2014, as amended, which gives legal protection to workers, which includes Directors and Shareholders, who make disclosures, including protections against dismissal or being penalised by the ICAV. Further details are available in the policy, which is available on request from the ICAV.
25. Approval of Annual Report and Audited Financial Statements
The Condensed Interim Report and Unaudited financial statements were approved by the Directors on 27 August 2025.
Page 41
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 38
Schedule of InvestmentsAs at 30 June 2025Chimera S&P UAE UCITS ETF
Security Description Nominal Fair Value AED
% ofNet Assets
Transferable securities admitted to an official stock exchange Equities 99.80% (31 December 2024: 99.83%)
United Arab Emirates 99.80% (31 December 2024: 99.83%)
Abu Dhabi Commercial Bank PJSC784,86010,579,9136.63
Abu Dhabi Islamic Bank PJSC389,4318,372,7675.24
Abu Dhabi National Energy Co PJSC904,1583,173,5951.99
Abu Dhabi National Oil Co for Distribution PJSC770,6592,828,3191.77
ADNOC Drilling Co PJSC686,2223,911,4652.45
Adnoc Gas Plc1,851,6266,332,5613.97
ADNOC Logistics & Services376,8091,755,9301.10
Aldar Properties PJSC1,011,6589,023,9895.65
Americana Restaurants International Plc - Foreign Co767,7201,727,3701.08
Apex Investment Co PSC190,985742,9320.47
Borouge Plc805,7122,046,5081.28
Dubai Electricity & Water Authority PJSC2,412,4986,803,2444.26
Dubai Islamic Bank PJSC776,3687,041,6584.41
Emaar Development PJSC214,4442,894,9941.81
Emaar Properties PJSC1,658,49922,555,58614.13
Emirates NBD Bank PJSC660,34715,055,9129.43
Emirates Telecommunications Group Co PJSC932,48416,411,71810.28
Fertiglobe plc320,616763,0660.48
First Abu Dhabi Bank PJSC1,184,54919,663,51312.31
Ghitha Holding PJSC10,389312,0860.20
Lulu Retail Holdings Plc865,7821,090,8850.68
Modon Holding PSC876,3843,049,8161.91
Multiply Group PJSC900,6662,170,6051.36
NMDC Group PJSC56,5851,406,7030.88
Parkin Co PJSC201,0411,306,7670.82
Phoenix Group Plc861,5841,378,5340.86
Presight AI Holding Plc216,621662,8600.41
Pure Health Holding PJSC685,0301,842,7311.15
Salik Co PJSC502,6043,040,7541.90
Talabat Holding Plc1,061,2311,422,0500.89
Total United Arab Emirates159,368,83199.80
Page 42
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 39
Chimera S&P UAE UCITS ETF (continued)Security Description Nominal Fair ValueAED% ofNet Assets
Transferable securities admitted to an official stock exchange (continued) Equities 99.80% (31 December 2024: 99.83%) (continued)
United Arab Emirates 99.80% (31 December 2024: 99.83%) (continued)
Total Equities159,368,83199.80
Total Transferable securities admitted to an official stock exchange159,368,83199.80
Total Financial assets at fair value through profit or loss159,368,83199.80
Cash and cash equivalents3,723,2152.33
Net other liabilities(3,410,626)(2.13)
Total Net assets attributable to holders of redeemable participating
shares159,681,420100.00
Analysis of total assets% ofTotalAssets
Transferable securities admitted to an official stock exchange listing 97.72
Cash and cash equivalents 2.28Total Assets 100.00
Page 43
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 40
Schedule of InvestmentsAs at 30 June 2025 (continued)Chimera S&P Pakistan UCITS ETF
Security Description Nominal Fair Value PKR
% ofNet Assets
Transferable securities admitted to an official stock exchange Equities 97.09% (31 December 2024: 96.89%)
Pakistan 97.09% (31 December 2024: 96.89%)
Engro Fertilizers Ltd203,58037,782,4125.45
Fauji Cement Co Ltd322,96714,426,9362.08
Fauji Fertilizer Co Ltd276,140108,360,09715.64
Habib Bank Ltd218,55439,162,6915.65
Hub Power Co Ltd/The364,06650,171,9367.24
Lucky Cement Ltd152,28754,098,4347.81
Mari Energies Ltd83,20352,159,1297.53
Meezan Bank Ltd143,03247,493,7766.85
National Bank of Pakistan184,29620,031,1322.89
Oil & Gas Development Co Ltd223,54149,304,2037.11
Pakistan Petroleum Ltd235,70440,109,7505.79
Pakistan State Oil Co Ltd120,37845,446,3066.56
SUI Northern Gas Pipeline149,43417,440,4422.52
TRG Pakistan94,4895,339,5730.77
United Bank Ltd/Pakistan331,49791,476,59713.20
Total Pakistan672,803,41497.09
Total Equities672,803,41497.09
Total Transferable securities admitted to an official stock exchange672,803,41497.09
Total Financial assets at fair value through profit or loss672,803,41497.09
Cash and cash equivalents21,884,0563.16
Net other liabilities(1,746,335)(0.25)
Total Net assets attributable to holders of redeemable participating
shares692,941,135100.00
Analysis of total assets% ofTotalAssets
Transferable securities admitted to an official stock exchange listing 96.85
Cash and cash equivalents 3.15Total Assets 100.00
Page 44
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 41
Schedule of InvestmentsAs at 30 June 2025 (continued)Chimera JP Morgan UAE Bond UCITS ETFSecurity Description Nominal Fair ValueUSD% ofNet AssetsTransferable securities admitted to an official stock exchangeCorporate Bonds 83.55% (31 December 2024: –)Cayman Islands 40.27% (31 December 2024: 21.51%)
Aldar Investment Properties Sukuk Ltd 4.88% 24/05/2033246,000243,0794.76
BOS Funding Ltd 'EMTN' 7.00% 14/03/2028200,000208,1544.08
DIB Sukuk Ltd 'EMTN' 5.24% 04/03/2029200,000202,8123.97
DP World Crescent Ltd 'REGS' 3.75% 30/01/2030350,000333,1566.52
EI Sukuk Co Ltd 'EMTN' 2.08% 02/11/2026229,000220,2274.31
Emaar Sukuk Ltd 'EMTN' 3.64% 15/09/2026202,000199,4123.90
Esic Sukuk Ltd 5.83% 14/02/2029215,000217,8494.27
Fab Sukuk Co Ltd 5.15% 16/01/2030200,000205,4384.02
MAF Sukuk Ltd 4.64% 14/05/2029229,000226,7014.44
Total Cayman Islands2,056,82840.27
Jersey 3.38% (31 December 2024: 3.31%)
Galaxy Pipeline Assets Bidco Ltd 'REGS' 2.94% 30/09/2040210,211172,3083.38
Total Jersey172,3083.38
United Arab Emirates 39.90% (31 December 2024: 59.08%)
Abu Dhabi Commercial Bank PJSC 'GMTN' 4.50% 14/09/2027200,000199,9903.92
Abu Dhabi Crude Oil Pipeline LLC 'REGS' 4.60% 02/11/2047207,000185,0063.62
Abu Dhabi Developmental Holding Co PJSC 'REGS' 4.38% 02/10/2031245,000240,3574.71
Abu Dhabi National Energy Co PJSC 'REGS' 6.50% 27/10/2036200,000221,3684.34
Adnoc Murban Rsc Ltd 'REGS' 5.13% 11/09/2054200,000181,1253.55
Commercial Bank of Dubai PSC 'EMTN' 5.32% 14/06/2028230,000234,0964.58
Emirates NBD Bank PJSC 'EMTN' 5.63% 21/10/2027203,000208,5834.08
First Abu Dhabi Bank PJSC 'EMTN' 5.00% 28/02/2029205,000208,5884.09
MDGH GMTN RSC Ltd 'GMTN' 5.29% 04/06/2034200,000204,9634.01
MDGH GMTN RSC Ltd 'GMTN' 3.95% 21/05/2050200,000153,3123.00
Total United Arab Emirates2,037,38839.90
Total Corporate Bonds4,266,52483.55
Government Bonds 14.00% (31 December 2024: –) United Arab Emirates 14.00% (31 December 2024: 13.72%)
Abu Dhabi Government International Bond 'REGS' 5.00% 30/04/2034212,000219,2614.30
Abu Dhabi Government International Bond 'REGS' 3.13% 30/09/2049236,000160,0083.13
UAE International Government Bond 'REGS' 4.86% 02/07/2034201,000206,2864.04
UAE International Government Bond 'REGS' 3.25% 19/10/2061201,000129,3522.53
Total United Arab Emirates714,90714.00
Total Government Bonds714,90714.00
Page 45
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 42
Chimera JP Morgan UAE Bond UCITS ETF (continued) Security Description Nominal Fair Value
USD% ofNet Assets
Transferable securities admitted to an official stock exchange (continued) Mutual Funds 1.34% (31 December 2024: –)
Ireland 1.34% (31 December 2024: 1.28%)
Goldman Sachs plc - US$ Treasury Liquid Reserves Fund0.00%68,42868,4281.34
Total Ireland68,4281.34
Total Mutual Funds68,4281.34
Total Transferable securities admitted to an official stock exchange5,049,85998.89
Total Financial assets at fair value through profit or loss5,049,85998.89
Cash and cash equivalents4,7870.09
Net other assets51,7741.02
Total Net assets attributable to holders of redeemable participating
shares5,106,420100.00
Analysis of total assets% ofTotalAssets
Transferable securities admitted to an official stock exchange listing 98.76
Cash and cash equivalents 0.09Other assets 1.15Total Assets 100.00
Page 46
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 43
Schedule of InvestmentsAs at 30 June 2025 (continued)Chimera S&P Japan UCITS ETF
Security Description Nominal Fair Value JPY
% ofNet AssetsTransferable securities admitted to an official stock exchangeEquities 99.36% (31 December 2024: 99.76%)Japan 99.36% (31 December 2024: 99.76%)
Advantest Corp1,53816,387,3902.87
DeNA Co Ltd147392,7840.07
Disco Corp1867,929,1801.39
Fast Retailing Co Ltd41520,550,8003.60
Fujikura Ltd5554,201,9050.74
Hitachi Ltd9,19838,677,5906.78
Honda Motor Co Ltd9,75413,601,9532.38
IHI Corp3124,879,6800.86
Kawasaki Heavy Industries Ltd3393,695,1000.65
Keyence Corp40023,136,0004.06
Lasertec Corp (Units)1643,183,2400.56
Mitsubishi Corp8,07723,326,3764.09
Mitsubishi Heavy Industries Ltd6,77524,457,7504.29
Mitsubishi UFJ Financial Group Inc24,23348,054,0398.43
Mitsui OSK Lines Ltd7453,590,9000.63
Mizuho Financial Group Inc5,04820,156,6643.53
Nintendo Co Ltd2,34732,576,3605.71
Nippon Yusen KK9234,788,5240.84
Nissan Motor Co Ltd4,1621,457,5320.26
NTT Inc60,0059,240,7701.62
Recruit Holdings Co Ltd3,14026,799,9004.70
Renesas Electronics Corp3,2185,757,0021.01
Sanrio Co Ltd3952,752,3600.48
Shin-Etsu Chemical Co Ltd3,98619,021,1923.33
SoftBank Group Corp2,09622,039,4403.86
Sony Group Corp12,34946,061,7708.08
Sumitomo Mitsui Financial Group Inc7,80028,345,2004.97
Tokio Marine Holdings Inc3,88423,735,1244.16
Tokyo Electron Ltd94726,212,9604.60
Toyota Motor Corp24,74061,676,82010.81
Total Japan566,686,30599.36
Page 47
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 44
Chimera S&P Japan UCITS ETF (continued)Security Description Nominal Fair ValueJPY% ofNet Assets
Transferable securities admitted to an official stock exchange (continued) Equities 99.36% (31 December 2024: 99.76%) (continued)
Japan 99.36% (31 December 2024: 99.76%) (continued)
Total Equities566,686,30599.36
Total Transferable securities admitted to an official stock exchange566,686,30599.36
Total Financial assets at fair value through profit or loss566,686,30599.36
Cash and cash equivalents5,840,8871.02
Net other liabilities(2,188,228)(0.38)
Total Net assets attributable to holders of redeemable participating
shares570,338,964100.00
Analysis of total assets% ofTotalAssets
Transferable securities admitted to an official stock exchange listing 98.91
Cash and cash equivalents 1.02Other assets 0.07Total Assets 100.00
Page 48
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 45
Schedule of InvestmentsAs at 30 June 2025 (continued)Chimera S&P Germany UCITS ETF
Security Description Nominal Fair Value EUR
% ofNet AssetsTransferable securities admitted to an official stock exchangeEquities 99.77% (31 December 2024: 99.86%)Germany 99.77% (31 December 2024: 99.86%)
adidas AG31762,7502.27
Allianz SE738253,9469.20
BASF SE1,71071,5812.59
Bayer AG1,88148,0311.74
Bayerische Motoren Werke AG53340,2201.46
Beiersdorf AG18319,5080.71
Commerzbank AG1,90651,0431.85
Daimler Truck Holding AG94237,8401.37
Deutsche Bank AG3,73694,0353.41
Deutsche Boerse AG36099,6843.61
Deutsche Lufthansa AG1,0997,8910.29
Deutsche Post AG1,74768,5002.48
Deutsche Telekom AG6,670206,5707.48
Dr Ing hc F Porsche AG - Preference '144A'1687,0460.25
E.ON SE4,30067,1872.43
Fresenius SE & Co KGaA79633,9731.23
Heidelberg Materials AG25550,8601.84
Hensoldt AG11511,2010.41
Infineon Technologies AG2,50190,3243.27
Mercedes-Benz Group AG1,32966,0382.39
Merck KGaA24827,2800.99
Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen254139,8525.06
RENK Group AG523,5290.13
Rheinmetall AG83149,1515.40
RWE AG1,29745,9531.66
SAP SE1,948502,87618.21
Siemens AG1,437312,76311.33
Siemens Energy AG1,086106,4933.86
Volkswagen AG - Preference35131,4571.14
Vonovia SE1,57547,1081.71
Total Germany2,754,69099.77
Page 49
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 46
Chimera S&P Germany UCITS ETF (continued)Security Description Nominal Fair ValueEUR% ofNet Assets
Transferable securities admitted to an official stock exchange (continued) Equities 99.77% (31 December 2024: 99.86%) (continued)
Germany 99.77% (31 December 2024: 99.86%) (continued)
Total Equities2,754,69099.77
Total Transferable securities admitted to an official stock exchange2,754,69099.77
Total Financial assets at fair value through profit or loss2,754,69099.77
Cash and cash equivalents48,1051.74
Net other liabilities(41,666)(1.51)
Total Net assets attributable to holders of redeemable participating
shares2,761,129100.00
Analysis of total assets% ofTotalAssets
Transferable securities admitted to an official stock exchange listing 98.28
Cash and cash equivalents 1.72Total Assets 100.00
Page 50
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 47
Statement of Portfolio Changes for the financial Period Ended 30 June 2025 Chimera S&P UAE UCITS ETF
Major Purchases<Security Description Nominal CostAED
Borouge Plc805,7121,990,631
Talabat Holding Plc1,061,2311,382,111
Lulu Retail Holdings Plc865,7821,178,091
Emaar Properties PJSC83,0521,062,210
First Abu Dhabi Bank PJSC57,714796,701
Emirates Telecommunications Group Co PJSC45,432762,914
Emirates NBD Bank PJSC33,069664,488
Abu Dhabi Commercial Bank PJSC38,239404,757
Aldar Properties PJSC49,289398,451
Abu Dhabi Islamic Bank PJSC18,516303,435
Deyaar Development PJSC294,423274,615
Dubai Electricity & Water Authority PJSC92,605240,036
Dubai Islamic Bank PJSC29,802217,825
Adnoc Gas Plc64,028197,834
ADNOC Drilling Co PJSC27,271140,824
Abu Dhabi National Energy Co PJSC34,707109,703
Modon Holding PSC33,641102,295
Emaar Development PJSC8,232102,272
Abu Dhabi National Oil Co for Distribution PJSC29,58399,425
Salik Co PJSC19,29398,390
< In accordance with the Central Bank UCITS Regulations, the condensed interim report and unaudited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the period. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the period and/or aggregate disposals greater than 1 per cent of the total value of sales for the period. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.
Page 51
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 2025 48
Statement of Portfolio Changes for the financial Period Ended 30 June 2025 (continued) Chimera S&P UAE UCITS ETF
Major Sales<Security Description Nominal ProceedsAED
Emaar Properties PJSC87,3591,098,378
Adnoc Gas Plc275,108928,294
First Abu Dhabi Bank PJSC60,790912,500
Emirates Telecommunications Group Co PJSC47,854807,996
Emirates NBD Bank PJSC34,784726,151
Gulf Navigation Holding PJSC113,238595,921
Ajman Bank PJSC300,538467,979
Abu Dhabi Commercial Bank PJSC40,278460,145
Aldar Properties PJSC51,916417,436
Abu Dhabi Islamic Bank PJSC19,527363,118
Dubai Electricity & Water Authority PJSC98,870268,428
Deyaar Development PJSC294,423268,017
Dubai Islamic Bank PJSC31,818265,506
ADNOC Drilling Co PJSC29,053155,393
Eshraq Investments PJSC362,993133,909
Abu Dhabi National Energy Co PJSC37,055125,583
Salik Co PJSC20,598115,129
Abu Dhabi National Oil Co for Distribution PJSC31,584111,147
Emaar Development PJSC8,789107,898
Modon Holding PSC35,917106,645
< In accordance with the Central Bank UCITS Regulations, the condensed interim report and unaudited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the period. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the period and/or aggregate disposals greater than 1 per cent of the total value of sales for the period. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.
Page 52
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 2025 49
Statement of Portfolio Changes for the financial Period Ended 30 June 2025 (continued) Chimera S&P Pakistan UCITS ETF
All Purchases<Security Description Nominal CostPKR
Pakistan Oilfields Ltd47,05329,522,473
Fauji Fertilizer Co Ltd51,97919,665,114
National Bank of Pakistan184,29619,190,306
SUI Northern Gas Pipeline152,05917,312,562
Fauji Cement Co Ltd328,64015,376,863
Pakistan State Oil Co Ltd36,56515,311,455
United Bank Ltd/Pakistan29,53411,741,966
Hub Power Co Ltd/The53,3507,478,065
Oil & Gas Development Co Ltd27,7456,236,582
Engro Fertilizers Ltd26,8655,692,294
Pakistan Petroleum Ltd28,8215,483,864
Meezan Bank Ltd18,8754,711,160
Mari Energies Ltd3,6582,475,689
Lucky Cement Ltd2,5952,321,923
Habib Bank Ltd9,8001,645,790
MCB Bank Ltd4,2771,228,711
Systems Ltd1,291777,425
< In accordance with the Central Bank UCITS Regulations, the condensed interim report and unaudited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the period. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the period and/or aggregate disposals greater than 1 per cent of the total value of sales for the period. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.
Page 53
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 30 June 2025 50
Statement of Portfolio Changes for the financial Period Ended 30 June 2025 (continued) Chimera S&P Pakistan UCITS ETF
All Sales<Security Description Nominal ProceedsPKR
Engro Corp Ltd/Pakistan89,48543,282,222
MCB Bank Ltd149,69241,962,080
Systems Ltd60,90734,956,357
Pakistan Oilfields Ltd47,05325,224,301
Lucky Cement Ltd10,1618,202,316
United Bank Ltd/Pakistan12,5953,272,019
Habib Bank Ltd17,3912,764,447
Mari Energies Ltd3,5612,267,435
Pakistan State Oil Co Ltd4,8141,786,350
Meezan Bank Ltd5,7201,762,439
Hub Power Co Ltd/The11,7041,582,301
Oil & Gas Development Co Ltd7,1861,518,198
Engro Fertilizers Ltd8,1421,466,711
Pakistan Petroleum Ltd7,1431,165,008
SUI Northern Gas Pipeline2,625301,631
Fauji Cement Co Ltd5,673252,995
TRG Pakistan4,064229,711
< In accordance with the Central Bank UCITS Regulations, the condensed interim report and unaudited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the period. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the period and/or aggregate disposals greater than 1 per cent of the total value of sales for the period. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.
Page 54
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 2025 51
Statement of Portfolio Changes for the financial Period Ended 30 June 2025 (continued) Chimera JP Morgan UAE Bond UCITS ETF
All Purchases<Security Description Nominal CostUSD*
DP World Crescent Ltd 'REGS' 3.75% 30/01/2030350,000333,449
Goldman Sachs plc - US$ Treasury Liquid Reserves Fund273,347273,347
Abu Dhabi Developmental Holding Co PJSC 'REGS' 4.38% 02/10/2031245,000236,266
EI Sukuk Co Ltd 'EMTN' 2.08% 02/11/2026229,000220,740
Fab Sukuk Co Ltd 5.15% 16/01/2030200,000203,550
DIB Sukuk Ltd 'EMTN' 5.24% 04/03/2029200,000202,500
MDGH GMTN RSC Ltd 'GMTN' 5.29% 04/06/2034200,000202,302
Emaar Sukuk Ltd 'EMTN' 3.64% 15/09/2026202,000199,198
Adnoc Murban Rsc Ltd 'REGS' 5.13% 11/09/2054200,000185,480
< In accordance with the Central Bank UCITS Regulations, the condensed interim report and unaudited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the period. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the period and/or aggregate disposals greater than 1 per cent of the total value of sales for the period. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.
* The purchases consideration figures do not include interest.
Page 55
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 2025 52
Statement of Portfolio Changes for the financial Period Ended 30 June 2025 (continued) Chimera JP Morgan UAE Bond UCITS ETF
All Sales<Security Description Nominal ProceedsUSD*
Adnoc Murban Rsc Ltd 'REGS' 4.25% 11/09/2029360,000351,943
Goldman Sachs plc - US$ Treasury Liquid Reserves Fund269,995269,995
Abu Dhabi Ports Co PJSC 'EMTN' 2.5% 06/05/2031300,000262,317
DAE Sukuk Difc Ltd 'REGS' 3.75% 15/02/2026248,000245,210
Abu Dhabi Developmental Holding Co PJSC 'REGS' 5.38% 08/05/2029239,000242,492
Adib Sukuk Co II Ltd 5.70% 15/11/2028204,000210,489
MDGH GMTN RSC Ltd 'GMTN' 2.50% 21/05/2026206,000201,905
DP World Ltd/United Arab Emirates 'REGS' 5.63% 25/09/2048201,000191,513
DP World Ltd/United Arab Emirates 'REGS' 6.85% 02/07/2037130,000140,179
Galaxy Pipeline Assets Bidco Ltd 'REGS' 2.94% 30/09/20403,9273,927
< In accordance with the Central Bank UCITS Regulations, the condensed interim report and unaudited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the period. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the period and/or aggregate disposals greater than 1 per cent of the total value of sales for the period. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.
* The sales consideration figures do not include interest.
Page 56
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 2025 53
Statement of Portfolio Changes for the financial Period Ended 30 June 2025 (continued) Chimera S&P Japan UCITS ETF
Major Purchases<Security Description Nominal CostJPY
Tokio Marine Holdings Inc3,88423,252,686
Sanrio Co Ltd3952,782,349
Toyota Motor Corp9552,406,568
Mitsubishi UFJ Financial Group Inc9361,837,029
Nissan Motor Co Ltd4,1621,762,580
Sony Group Corp4761,753,396
Hitachi Ltd3551,432,701
Nintendo Co Ltd891,160,291
Mitsubishi Heavy Industries Ltd256886,583
Tokyo Electron Ltd36878,426
Mitsubishi Corp305859,238
Keyence Corp15851,675
Sumitomo Mitsui Financial Group Inc217778,418
SoftBank Group Corp79715,234
Fast Retailing Co Ltd15699,265
Shin-Etsu Chemical Co Ltd151669,091
Advantest Corp58578,411
Mizuho Financial Group Inc142561,508
Honda Motor Co Ltd368525,272
DeNA Co Ltd147397,139
< In accordance with the Central Bank UCITS Regulations, the condensed interim report and unaudited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the period. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the period and/or aggregate disposals greater than 1 per cent of the total value of sales for the period. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.
Page 57
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 2025 54
Statement of Portfolio Changes for the financial Period Ended 30 June 2025 (continued) Chimera S&P Japan UCITS ETF
Major Sales<Security Description Nominal ProceedsJPY
Mitsui & Co Ltd5,99617,521,610
Mitsubishi UFJ Financial Group Inc1,5873,527,625
Toyota Motor Corp1,0633,019,668
Kawasaki Kisen Kaisha Ltd1,3352,896,255
Sony Group Corp7192,715,652
SCREEN Holdings Co Ltd2032,201,006
Hitachi Ltd5091,915,040
Recruit Holdings Co Ltd1881,511,896
Sumitomo Mitsui Financial Group Inc3261,343,713
Nintendo Co Ltd991,064,793
Mitsubishi Corp341948,417
Keyence Corp14849,599
Mizuho Financial Group Inc181805,625
Shin-Etsu Chemical Co Ltd175777,474
Fast Retailing Co Ltd17763,990
Tokyo Electron Ltd34750,540
Mitsubishi Heavy Industries Ltd240689,030
Socionext Inc330680,960
Honda Motor Co Ltd411617,021
SoftBank Group Corp75592,516
< In accordance with the Central Bank UCITS Regulations, the condensed interim report and unaudited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the period. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the period and/or aggregate disposals greater than 1 per cent of the total value of sales for the period. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.
Page 58
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 2025 55
Statement of Portfolio Changes for the financial Period Ended 30 June 2025 (continued) Chimera S&P Germany UCITS ETF
All Purchases<Security Description Nominal CostEUR
Heidelberg Materials AG25544,818
SAP SE4612,101
Hensoldt AG11510,875
Deutsche Telekom AG1835,692
Siemens AG265,435
Allianz SE113,905
RENK Group AG523,615
Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen42,299
Rheinmetall AG11,753
Deutsche Bank AG551,361
Fresenius SE & Co KGaA281,210
Covestro AG '144A'181,088
Mercedes-Benz Group AG191,025
Deutsche Post AG261,023
< In accordance with the Central Bank UCITS Regulations, the condensed interim report and unaudited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the period. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the period and/or aggregate disposals greater than 1 per cent of the total value of sales for the period. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.
Page 59
Chimera UCITS ICAV
Condensed Interim Report & Unaudited Financial Statements For the financial period from 1 January 2025 to 2025 56
Statement of Portfolio Changes for the financial Period Ended 30 June 2025 (continued) Chimera S&P Germany UCITS ETF
All Sales<Security Description Nominal ProceedsEUR
SAP SE802204,163
Siemens AG582113,738
Allianz SE31195,406
Deutsche Telekom AG2,76585,793
Muenchener Rueckversicherungs-Gesellschaft AG in Muenchen10553,505
Mercedes-Benz Group AG75141,713
Deutsche Boerse AG14433,480
Symrise AG - Class A35533,254
Infineon Technologies AG99333,211
adidas AG12630,807
Covestro AG '144A'50830,302
BASF SE67829,725
Deutsche Bank AG1,65629,551
Deutsche Post AG75125,968
Rheinmetall AG3524,755
Siemens Energy AG43222,969
E.ON SE1,70719,622
Vonovia SE62618,736
Bayerische Motoren Werke AG21216,369
RWE AG51415,307
Bayer AG74715,099
Daimler Truck Holding AG38014,575
Merck KGaA9813,796
Porsche Automobil Holding SE - Preference39913,650
Commerzbank AG75612,928
Volkswagen AG - Preference14012,652
Fresenius SE & Co KGaA31711,193
< In accordance with the Central Bank UCITS Regulations, the condensed interim report and unaudited financial statements documents material changes that have occurred in the disposition of the assets of the ICAV during the period. A material change is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the period and/or aggregate disposals greater than 1 per cent of the total value of sales for the period. If there are fewer than 20 purchases/sales that meet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.
Page 60
Chimera UCITS ICAVCondensed Interim Report & Unaudited Financial StatementsFor the financial period from 1 January 2025 to 202557
Appendix I: Securities Financing Transactions Regulation (“SFTR”) Disclosures
The ICAV is required to report in the financial statements on a semi-annual basis, certain disclosures as set out in Article 13 of the European Commission Regulation 2015/2365 on transparency of securities financing transactions and of reuse of collateral (the “Regulation”).
Neither the ICAV nor the Sub-Funds engaged in any securities financing transactions during the financial period ended 30 June 2025, as a result, there is nothing to report in that regard.